Arthneeti

Hemant Surgical Industries Share Price & Earnings Call Analysis

₹597.35+2.16% today
Market cap
₹868 Cr
P/E
51.29
ROE
16.89%
PEG
1.70
Price to sales
3.76
Debt to equity
0.36
52W high / low
₹666 / ₹218
Sales growth (5Y)
31.02%
EBITDA margin
10.13%
Net profit margin
7.33%
Promoter holding
52.83%
Sales (last year)
₹231 Cr

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Molbio DiagnostiGood growth
    3
See all potential multibaggersWhere does Hemant Surgical rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Equipment & Supplies companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Flat₹598 Cr20.4
240%+Flat₹139 Cr15.9
3Molbio Diagnosti20–40%Flat₹14,682 Cr67.6
420–40%Flat₹160 Cr32.4
510–20%Up 2%+₹143 Cr15.9
610–20%Up 0–2%₹755 Cr62.3

Sign up free to see every company in the sector ranking and track Hemant Surgical.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Equipment & Supplies ranking

Financials of Hemant Surgical

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Hemant Surgical

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Hemant Surgical

Profit & Loss

Annual income statement trend

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +51565660101109106107231
Expenses +4853535795989597208
Operating Profit233361110923
OPM %5%5%5%5%6%10%10%9%10%
Other Income +000122456
Interest112222124
Depreciation010111112
Profit before tax1111610131124
Tax %10%8%41%9%25%24%23%23%23%
Net Profit +11015810818
EPS in Rs50.7661.0227.0073.43248.929.959.397.7913.98
Dividend Payout %0%0%0%0%0%0%0%0%0%

Financials of Hemant Surgical

Balance Sheet

Capital structure and asset base

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital222228101013
Reserves565811164453124
Borrowings +911141410773150
Other Liabilities +121423153234385487
Total Liabilities283344405465100148274
Fixed Assets +7810111213184053
CWIP0000000120
Investments001010510
Other Assets +2125332942517794220
Total Assets283344405465100148274

Financials of Hemant Surgical

Cash Flows

Operating, investing and financing cash movement

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +002-4126-49-32
Cash from Investing Activity +00-2-2-0-3-12-30-3
Cash from Financing Activity +0025-8-1211869
Net Cash Flow002-2435-434
Free Cash Flow00-1-7122-13-25-34
CFO/OP0%0%68%-127%197%84%-9%126%-118%

Financials of Hemant Surgical

Ratios

Working capital efficiency and return ratios

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3536352656587570106
Inventory Days6473125113576799205120
Days Payable102971438992110116188146
Cash Conversion Cycle-31217512115588780
Working Capital Days1223-2841-192526124
ROCE %15%12%14%32%45%30%16%20%
96out of 100

Momentum score · price trend

96 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+103.0%94%
Last 6 months+95.9%97%
Last 3 months+54.8%98%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Hemant Surgical: 0.4 × 94 + 0.4 × 97 + 0.2 × 98 = 96.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Healthcare Equipment & Supplies this season

  • Laxmi Dental (Q2 FY27)

    Q2FY27 revenue from operations: INR 795.2 mn, a 10.0% year-on-year (YoY) increase from INR 722.7 mn in Q2FY26. Key investor presentation takeaways from Laxmi De

  • Galaxy Medicare (Q2 FY27)

    Revenue from Operations (₹ Mn): . Key investor presentation takeaways from Galaxy Medicare's Q2 FY27 investor presentation — and how it ranks against sector pee

  • Nureca Ltd (Q2 FY27)

    Year-on-year growth in revenue from operations: approximately 55% increase (585.99 vs 378.41 million standalone) . Key results statement takeaways from Nureca's

  • Aprameya Enginee (Q2 FY26)

    H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26

Compare:vs Molbio Diagnostivs Poly Medicurevs Sahajanand Medi